GlassScriptPhysician profile
Laura K Brown
NPI 1053483313
$2,642.02
in general payments reported to CMS, 2019-2025
19 companies · $679 in 2025
The $679 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.07 · 2020: $150 · 2021: $224 · 2022: $776 · 2023: $384 · 2024: $378 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,441.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $496.05 | 2022-2025 | Amo Phaco Needle, Tecnis Simplicity |
| Sun Pharmaceutical Industries INC. | $410.16 | 2020-2025 | Cequa |
| Bausch & Lomb Americas INC. | $252.40 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Oyster Point Pharma, INC. | $252.31 | 2022-2025 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $240.89 | 2021-2025 | |
| Harrow Eye, LLC | $240.64 | 2024-2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $207.55 | 2024-2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $121.28 | 2020-2021 | |
| Dompe US, INC. | $119.29 | 2022 | |
| Coopervision INC. | $73.60 | 2019-2021 | |
| Alcon Vision LLC | $47.66 | 2024-2025 | Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $44.90 | 2021 | |
| Genzyme Corporation | $32.06 | 2023 | |
| Novartis Pharmaceuticals Corporation | $26.36 | 2021-2022 | |
| Allergan, INC. | $23.61 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $20.59 | 2024 | Iyuzeh |
| Shire North American Group INC | $18.11 | 2019 | |
| Biotissue Holdings INC. | $14.56 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.